Thanks, Peter. I'll provide a brief overview, and of course, welcome all of you to review our filings in greater detail or to reach out to our team with questions you may have. During the quarter ended December 31, 2021, we reported consolidated revenue of $16.7 million, a net loss of $4.2 million and adjusted EBITDA of $1.4 million. For the same period last year, we reported consolidated revenue of $15.3 million, a net loss from continuing operations of $0.9 million and adjusted EBITDA of $0.9 million. Great Elm reports the results of each of our two operating segments, including Durable Medical Equipment and Investment Management as well as unallocated general corporate activity. We'll begin with a review of Durable Medical Equipment. For the fiscal second quarter, DME generated $15.7 million in revenue compared to; $14.5 million for the same period last year. The increase in revenues was driven by a record gross resupply sales as well as from contributions from recent acquisitions, AMPM and MedOne. In addition, our previous investments into the business has significantly improved the intake and collections process, resulting in a sustainable reduction in revenue reserves of $0.7 million as compared to the prior year period. We improved our gross margins at DME, increasing to 61.6% as compared to 56.5% in the prior year period. In addition to the efficiencies, reducing revenue reserves, the improved margins are also driven by improved vendor pricing as compared to the prior period. Great Elm's DME operations reported net income of $0.9 million in comparison to a net loss of $2.9 million in the prior year period. The prior year period includes a nonrecurring loss on the extinguishment of the Corbel note of $1.9 million. The net income comparison of the DME segment is also impacted by the recurring valuation adjustment of the embedded derivative, which is eliminated in consolidation and added back for EBITDA purposes. Adjusted EBITDA, a non-GAAP measure, was $2.6 million compared to $1.9 million in the same period in the prior year, an increase of nearly 40%. Next, turning to Investment Management. For the fiscal second quarter, Investment Management reported total revenue of $1.0 million compared to $0.8 million during the same period in the prior year. Revenue for the quarter was higher due to increases in the average assets on which such fees are calculated. Adjusted EBITDA was negative $47,000 in the fiscal second quarter compared to positive $33,000 during the same period in the prior year. Adjusted EBITDA for the quarter was impacted primarily by increased employee-related costs and professional fees related to investment management growth initiatives. Moving on to our general corporate segment. For the fiscal second quarter, Great Elm's General Corporate segment recognized $172,000 in revenue compared to $45,000 in revenue during the same period in the prior year. Revenue increased as a result of increased management fees earned from DME along with management fees earned from GEG's majority-owned subsidiary, Forest Investments, Inc. under a management agreement put into place in December 2020. General corporate adjusted EBITDA for the current quarter was negative $1.2 million compared to negative $1.0 million during the same period in the prior year. Great Elm continues to focus on rationalizing our corporate overhead and put us in the best position to execute our strategy. We ended the quarter with a healthy liquidity position of $25 million in cash, exclusive of liquid investments. This concludes my financial review of the quarter, and I'll turn it back to Peter for closing remarks.